Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Herbal extracts like Ficus religiosa may help with hair growth and skin rejuvenation.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

PCOS is a common hormonal disorder in women that can be managed with lifestyle changes and various medications.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Finasteride reduces hair growth and is safe for women with excessive hair.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Many women with postadolescent acne also have hormonal imbalances and are at higher risk for metabolic issues.

Hair loss linked to higher heart disease risk in both men and women.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

PRP shows promise for treating hair loss, but more research is needed.

New methods improve how we test hair growth treatments, but challenges like slow hair changes and high costs remain.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.